Investor Overview
VYNE Therapeutics™ is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.22
Oct. 01, 2022 19:26:36- Change -0.0121 (-5.144556%)
- Volume 101,037
- Today's Open 0.2423
- Previous Close 0.2352
- Today's High 0.245
- Today's Low 0.2231
- 52 Week High 1.75
- 52 Week Low 0.221